A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
UZ Leuven is a university hospital where patients can count on specialized care and innovative treatments, combined with human attention and respect for each person. Almost 10,000 passionate employees provide the best tailored care every day.
Leuven, Belgium Clinical Trial Location
Leuven Cancer Institute
Herestraat 49 campus, 3000